SBIR-STTR Award

  1. You are here:    Home
  2. Search Databases
  3. Search SBIR-STTR Awards
  4. SBIR-STTR Award

Recombinant West Nile Virus Vaccine Adjuvanted with SLA-LSQ
Award last edited on: 4/27/2023

Sponsored Program
SBIR
Awarding Agency
NIH : NIAID
Total Award Amount
$2,997,219
Award Phase
2
Solicitation Topic Code
105
Principal Investigator
David E Clements

Company Information

Hawaii Biotech Inc (AKA: Hawaii Biotech Inc~Panthera Biopharma LLC)

650 Iwilei Road Suite 204
Honolulu, HI 96817
   (808) 486-5333
   info@hibiotech.com
   www.hibiotech.com
Location: Single
Congr. District: 01
County: Honolulu

Phase I

Contract Number: N/A
Start Date: 7/5/2022    Completed: 7/5/2025
Phase I year
2022
Phase I Amount
$1
Direct to Phase II

Phase II

Contract Number: 75N93022C00034
Start Date: 7/5/2022    Completed: 7/5/2025
Phase II year
2022
Phase II Amount
$2,997,218
The contract supports the development of TLR4 agonist within an oil-in-water emulsion as a vaccine adjuvant. The adjuvant development activities are being conducted within the context of vaccines to protect against West Nile virus infection.